Murdo is a Director and a member of the Healthcare sector team. He joined Bridgepoint in 2016.
He has worked on a number of transactions, including Pharmazell and Novasep (now Axplora), Vermaat, Nuvias, and MyDentist. He has also been involved in portfolio management and sat on the boards of WiggleCRC, Care UK and MiQ.
Prior to joining Bridgepoint Murdo worked at L.E.K. Consulting in London and Boston, advising on PE due-diligence and corporate strategy projects, primarily in Healthcare and Services. Raised in Scotland, Murdo is based in London, and holds a degree in History and Politics from the University of Oxford.